Nxera Pharma Co., Ltd. (TYO:4565)
Japan · Delayed Price · Currency is JPY 827.00
-21.00 (-2.48%)
Feb 6, 2026, 3:30 PM JST
Nxera Pharma Market Cap
Nxera Pharma has a market cap or net worth of 74.84 billion as of February 6, 2026. Its market cap has decreased by -15.57% in one year.
Market Cap
74.84B
Enterprise Value
109.52B
Revenue
28.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
827.00
Market Cap Chart
Since July 29, 2004, Nxera Pharma's market cap has increased from 38.40B to 74.84B, an increase of 94.91%. That is a compound annual growth rate of 3.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 76.74B | 2.54% |
| Dec 30, 2025 | 74.84B | -20.57% |
| Dec 30, 2024 | 94.22B | -25.87% |
| Dec 29, 2023 | 127.10B | -27.43% |
| Dec 30, 2022 | 175.15B | 12.85% |
| Dec 30, 2021 | 155.21B | 7.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PeptiDream | 198.67B |
| SanBio Company | 148.50B |
| GNI Group | 139.73B |
| Takara Bio | 96.69B |
| Cuorips | 68.55B |
| Oncolys BioPharma | 50.53B |
| Healios K.K. | 46.99B |
| RaQualia Pharma | 26.40B |